Bayer Crop Science Ventures
Bayer's venture arm investing in agricultural technology, digital farming, and crop science innovation.
This is corporate VC with all the pros and cons that entails. The upside: massive distribution potential, regulatory expertise, and deep pockets for follow-on rounds. Bayer has real customers who will actually use your product if it works. The downside: they move slowly, have complex internal approval processes, and may prioritize strategic value over pure financial returns. Founders report that deals can take forever to close, but once you're in, they're committed partners who provide real market access. Just don't expect Silicon Valley-style speed or risk appetite.
- —Best for: B2B agtech startups needing industry expertise and customer access
- —Watch out for: Slow decision-making and complex corporate approval processes
- —Known for: Deep technical knowledge and massive distribution potential
Bayer Crop Science Ventures backs breakthrough technologies that transform agriculture and food systems. They focus on digital agriculture, biologicals, breeding innovation, and sustainable farming solutions that align with Bayer's mission to feed a growing world population.
Early to growth stage investments exclusively in agtech, with heavy emphasis on digital farming platforms, precision agriculture tools, plant breeding tech, and biologicals. Portfolio skews toward B2B solutions that integrate with or complement Bayer's existing crop science business.
Former McKinsey consultant who joined Bayer's venture arm to lead investments in digital agriculture and sustainability. Known for systematic approach to due diligence and strong network in precision ag space.
PhD in plant biology with previous venture experience at Khosla Ventures. Focuses on biologicals and breeding technologies, brings deep technical expertise to biotech deals in the portfolio.
Have a specific question about Bayer Crop Science Ventures?
Ask Bernie →